Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Coya Therapeutics (COYA) Assets Average (2023 - 2025)

Coya Therapeutics' Assets Average history spans 3 years, with the latest figure at $32.7 million for Q3 2025.

  • For Q3 2025, Assets Average fell 13.24% year-over-year to $32.7 million; the TTM value through Sep 2025 reached $32.7 million, down 13.24%, while the annual FY2024 figure was $42.8 million, 72.4% up from the prior year.
  • Assets Average for Q3 2025 was $32.7 million at Coya Therapeutics, down from $35.9 million in the prior quarter.
  • Across five years, Assets Average topped out at $41.4 million in Q1 2025 and bottomed at $12.9 million in Q1 2023.
  • The 3-year median for Assets Average is $35.9 million (2025), against an average of $30.4 million.
  • The largest annual shift saw Assets Average skyrocketed 204.7% in 2024 before it decreased 13.24% in 2025.
  • A 3-year view of Assets Average shows it stood at $26.6 million in 2023, then surged by 50.31% to $39.9 million in 2024, then decreased by 18.03% to $32.7 million in 2025.
  • Per Business Quant, the three most recent readings for COYA's Assets Average are $32.7 million (Q3 2025), $35.9 million (Q2 2025), and $41.4 million (Q1 2025).